We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Desktop Analyzer Performs Chemical, Turbidimetric Tests, and Immunoassays

By LabMedica International staff writers
Posted on 10 Nov 2010
A desktop analyzer uses innovative technology to allow simultaneous measurement of immunoassays and clinical chemistry parameters, including turbidimetric tests in one sample.

The fully automated, random access analyzer is ideal for medium-sized and small laboratories, and it will provide diagnostic services to hospitals, clinics, and large medical practice facilities.

The analyzer, which is called DRG:Hybrid-XL, is also ideal for high work-load labs performing routine and niche diagnostic parameters on large automatic equipment. More...
Up to 40 tests of different types or 40 times the same test, or up to 20-patient samples can be ordered by the medical practitioner over a wide range of prepackaged tests to serve different specialties, such as gynecology, oncology, prenatal supervision, cardiac markers, infectious diseases, and other common diseases.

DRG (Mountainside, NJ, USA) plans to showcase the new analyzer DRG:Hybrid-XL at MEDICA 2010, which will take place for four days from November 17, 2010 in Düsseldorf, Germany. It will be available for use in summer 2011.

Cyril E. Geacintov Ph.D., founder, CEO, and president of DRG, said, "The DRG:Hybrid-XL will allow laboratories to conduct specific testing on-site,” he says. "This will provide for faster and more accurate test results with greater convenience.”

Related Links:

DRG International Inc.






Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.